Matthew Galsky, MD

Clinical Focus

• Bladder Cancer
• Kidney Cancer
• Primary Pulmonary Hypertension
• Prostate Cancer
• Testicular Cancer
• Testicular Tumors
• Urologic Cancers

• Bladder Cancer
• Kidney Cancer
• Primary Pulmonary Hypertension
• Prostate Cancer
• Testicular Cancer
• Testicular Tumors
• Urologic Cancers

Locations

Ruttenberg Treatment Center

1470 Madison Avenue, 3rd Floor, New York, NY, 10029

212-241-6756

Insurance Information

Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.

Patients with Cigna Medicare Advantage or Humana Medicare Advantage insurance: Please read this important message before booking to find out if out-of-network costs may apply to your next visit.

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Selected Publications

• Molecular heterogeneity in urothelial carcinoma and determinants of clinical benefit to PD-L1 blockade. Habib Hamidi, Yasin Senbabaoglu, Niha Beig, Juliette Roels, Cyrus Manuel, Xiangnan Guan, Hartmut Koeppen, Zoe June Assaf, Barzin Y. Nabet, Adrian Waddell, Kobe Yuen, Sophia Maund, Ethan Sokol, Jennifer M. Giltnane, Amber Schedlbauer, Eloisa Fuentes, James D. Cowan, Edward E. Kadel, Viraj Degaonkar, Alexander Andreev-Drakhlin, Patrick Williams, Corey Carter, Suyasha Gupta, Elizabeth Steinberg, Yohann Loriot, Joaquim Bellmunt, Petros Grivas, Jonathan Rosenberg, Michiel S. van der Heijden, Matthew D. Galsky, Thomas Powles, Sanjeev Mariathasan, Romain Banchereau. Cancer Cell
• Atezolizumab monotherapy for metastatic urothelial carcinoma: final analysis from the phase II IMvigor210 trial. J. E. Rosenberg, M. D. Galsky, T. Powles, D. P. Petrylak, J. Bellmunt, Y. Loriot, A. Necchi, J. Hoffman-Censits, J. L. Perez-Gracia, M. S. van der Heijden, R. Dreicer, I. Durán, D. Castellano, A. Drakaki, M. Retz, S. S. Sridhar, P. Grivas, E. Y. Yu, P. H. O'Donnell, H. A. Burris, S. Mariathasan, Y. Shi, E. Goluboff, D. Bajorin. ESMO Open
• The Association of Statin Use With Survival Outcomes in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated With Androgen Receptor Targeted Therapies (ART). Zakaria Chakrani, Mann Patel, George Mellgard, Stephen McCroskery, Nathaniel Saffran, Nicole Taylor, Bobby C. Liaw, Matthew Galsky, William Oh, Che Kai Tsao, Teja Ganta, Vaibhav Patel. Clinical Genitourinary Cancer

Industry Relationships